NLARx is at NCSL Next Week
Join us next week at the National Conference of State Legislatures Annual Summit in Philadelphia. NLARx is hosting two informative panels: "Do Trade Policies Threaten Access to Affordable Medicines in the States?" (July 21) and "Data, Drugs and Disclosure: States Lead the Way on Pharmaceutical Policy" (July 24). See our website for details: More
|
NLARx News
NLARx and Community Catalyst Counter Dataminers' Claims that Marketing Improves Quality More
|
In the States
MASSACHUSETTS: Senior Citizens Protest Cuts to Coverage More
MICHIGAN: Attorney General Cox Targets Medicaid Fraud More
ILLINOIS: Survey Shows State's Seniors Delay Buying Prescription Drugs More
ALABAMA: Judge Declares Mistrial in Alabama-Watson Drug Case More |
Events
2009 International Symposium on Pharmaceuticals in the Home & Environment More |
Prices and Access to Healthcare
Complexity, Lack Of Transparency Hinder Patient Assistance Programs MoreEurope pays 40% less for drugs than U.S. MoreSavings From Hospitals, Insurers & Pharma Could Top $300 Billion MoreOverview of Approaches to Control Prescription Drug Spending in Federal Programs MoreAbbott Wins Ruling Tossing AIDS-Drug Monopoly Claims More |
Patents and Generics
Removing Obstacles to Generic Drug Competition More
Senate Panel OKs 12-Year Biologic Drug Exclusivity More
GPhA Calls Senate HELP Committee Action on Biogenerics Disappointing for Patients More
High Tech Drug Companies Receive Protection From Generics More
When Should Biotech Drugs Face Generic Competition? More
Delaying Generic Drugs Costs Patients & Taxpayers, EU Says More
Scrutiny on Two Continents for 'Pay for Delay' More
U.S., EU Getting Tough on "Pay-for-Delay"
More
Antitrust: Shortcomings in the Pharmaceutical Sector Require Further Action More
Are We Moving Towards Global Patenting? More
Pfizer Loses Norvasc Patent Fight in Canada More
|
Importation and Trade
Senate Votes to Allow Online Purchases of Canadian Drugs More
Drug Reimportation Passes Senate, for Now More
PhRMA Statement on Prescription Drug Importation More
White House Assures Drug Makers on Reimportation More
Pharma Gets White House Reimportation Pledge More
Prospects for Legalizing Drug Importation to US More
Approving Imported Drugs Is Good Medicine More
Summary of H.R. 2293 - The Public Health Trade Advisory Committee Act More
|
Conflicts of Interest
JAMA Eases Stand on Public Complaints About Conflicts of Interest More
JAMA Conflicts of Interest Policy: Now You See It, Now You Don't More
Survey: What Do You Think of Banning Drug Industry Gifts to Doctors? More
Obama Health Czar Made Millions from Companies Under Federal Investigation More |
Advertising and Marketing
How J&J Marketed Tylenol After Acetaminophen Hearings More
TV Networks Go to Bat for Drug Makers (and Themselves) More
Pharma Marketers are Salivating in Anticipation of Mental Health "Epidemic" More
I've Seen the Online Advertising Revolution and It's Not Working More
Can Pharma Use Social Media to Provide Patient Support? More
Pfizer's Slumdog Sales Rep More
|
Pharma Watch
Drug Industry Increases Lobbying Efforts And Targets Democrats More
Congress' $1.2 Million a Day Drug Habit - and Pharma's Phony 'Gift' to Health Care Reform More
Update on the Pharma Financial Crisis More
Pharma's eternal dilemma: Marketing or R&D? More
Big Pharma Looks To Branded Generics In Developing World More
Drug Firms See Poorer Nations as Sales Cure More
Pharma at Risk Again as Reform Efforts Stall More
Approval of Effient, a Plavix Rival, Boosts Japanese Drug Maker More
|
PBM Watch
Anthem Change Frustrates Pharmacists More
CVS Chief's Pay Outpaces Competitors' More
|
Medicare and Medicaid
Study Examines Cost, Benefits Of Extending Medicare Drug Use More
With Medicare Plan, Drug Spending May Be Up More
PhRMA's $80 Billion in Part D Concessions May Drive Up Health Plan Drug Costs More
Prescription Drug Donut Hole: 'Sweetheart Deal' for Big Pharma More
Middle Alabama Area Agency on Aging Uses Funds to Educate Seniors on Medicaid Plans More
|
Electronic Records
Who Really Profits From Digital Medical Records? MoreState Privacy Laws Could Be Slowing Electronic Medical Record Adoption MorePaperless Health Care? One Hospital's Long Journey MoreU.K. Mulls Handing Off National Health Records to Microsoft, Google More |
Safety and Clinical Trials
An M.D. On How Money Drives Medical Testing MoreContract Manufacturer Recall Slams Eight Drugmakers MoreGPhA Applauds House Action to Increase Funding for FDA's Office of Generic Drugs MoreUsing EPO in Cancer Is Harmful, Review Confirms MoreAcid-Reducing Medicines May Lead to Dependency MoreLess Prevnar May Be Just As Good. Don't Expect Changes Soon MoreMultaq Approval Marks Comeback for Sanofi's Heart Drug MoreWHO: Put Health Workers First In Line for Swine Flu Vaccine
More |
